Antihypertensive Drugs Market

The Antihypertensive Drugs Market is valued at USD 24.11 Billion in 2021 and is expected to reach USD 29.35 Billion by 2028 with a CAGR of 2.85% over the forecast period.

Increasing irregular and unhealthy lifestyles are leading to hypertension and therefore, majorly driving the market growth.

Market Analysis of Antihypertensive Drugs-

Antihypertensives are a class of drugs that are used to treat high blood pressure that is hypertension. The hypertensive drugs seek to prevent the difficulties of hypertension as myocardial infarction (heart attack) and strokes. The anti-hypertension drugs are used for leveling or reducing blood pressure. Hypertension is a chronic condition, in which the blood pressure is elevated abnormally systolic as well as diastolic. This is major risk factor for causing cardiovascular, renal or endocrine disorders. The drugs comprise numerous classes of compounds with the therapeutic intention of preventing, controlling, or treating hypertension. The ultimate goal of antihypertensive drugs is to reduce cardiovascular morbidity and mortality. These are frequently used by patients and may influence the conduct of anesthesia. These drugs have diverse indications, both cardiac and non-cardiac. Comparatively, limited drug classes are used to treat hypertension, the newest among them are direct renin inhibitors. The renin-angiotensin system is targeted at different points by many of the commonly used antihypertensive drugs.

The antihypertensive Drugs market report is segmented on the basis of type, application and region & country level. Based upon type, the antihypertensive drugs market is segmented into ARB, CCB and others. Based on application, antihypertensive drugs market is segmented into hypertension, PAH and others.

Antihypertensive Drugs Market Key Players:-

Some major key players for the antihypertensive drugs market are -

• Actelion
• Astra Zeneca
• Bayer
• Boehringer Ingelheim GmbH
• Boryung Pharmaceutical
• Cipla
• Daiichi Sankyo
• Gilead
• GlaxoSmithKline plc
• Johnson & Johnson
• JW Pharmaceutical
• Kolmar Korea
• Lupin
• Medtronic
• Merck
• Novartis
• Pfizer
• Sanofi
• Takeda
• United Therapeutics
• Others

Antihypertensive Drugs Market Segmentation:

By Drug Class

• Angiotensin-Converting Enzyme (ACE) Inhibitors
• Angiotensin Receptor Blockers (ARBs)
• Beta Blockers
• Calcium Channel Blockers
• Diuretics
• Renin Inhibitors
• Alpha Blockers
• Vasodilators

By Type of Hypertension

• Primary Hypertension
• Secondary Hypertension

By Route of Administration

• Oral
• Injectable

By Distribution Channels

• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies

By Regional & Country Analysis:

• North America

• U.S.
• Mexico
• Canada

• Europe

• UK
• France
• Germany
• Italy

• The Asia Pacific

• China
• Japan
• India
• Southeast Asia

• South America

• Brazil,
• Argentina
• Columbia

• The Middle East and Africa

• GCC
• Africa
• Rest of the Middle East and Africa

Antihypertensive Drugs Market Dynamics:-

Growing awareness about hypertension with increasing predominance, fix dose blending therapies and increased epidemic proportion of hypertension are the major factors driving the growth of global antihypertensive drugs market. In addition to this, irregular lifestyles with food habits, changes in lifestyle, aging regardless of demography and supplemented stress level are also supplementing the growth of antihypertensive drugs market. However, side effects of drugs such as; cough, diarrhea, nervousness, constipation, dizziness and weakness and increased risk of genericization may hamper the growth of market.

Moreover, increasing research and development for the novel pipeline drugs are expected more to fuel antihypertensive market in the forthcoming period. Pulmonary hypertensive practices offering training programs for people, high predominance of incessant illness, initiatives taken by government and the growing commonness of hypertension in youth population are also supporting the revenue opportunities for the antihypertensive drugs market.

Antihypertensive Drugs Market Regional Analysis-

The antihypertensive drugs market by region is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East and Africa. North America is expected to capture the largest market share owing to the high prevalence of hypertension related to renal and cardiovascular disorders in this region. Running drives by non-government and government organizations for spreading awareness among people are mostly bottling revenue generation opportunities in North America. As per the American Heart Association, under the updated guideline, more people will be diagnosed with hypertension, nearly half of American adults (46%), up from 32% under the previous definition.

Europe is expected to capture the second position due to the prevalence of cardiovascular diseases, improper diet habits, increasing obesity in children as well as in adults and high prevalence of hypertension that leads to death or disabilities in people. Asia-Pacific region will witness high growth in the antihypertensive drugs market owing to the high incidences of cardiovascular diseases, government initiatives taken for healthcare sector and high population pool.

Report Analysis	Details
Historical data	2015 - 2020
Forecast Period	2021 - 2028
Market Size in 2021:	USD 24.11 Billion
Base year considered	2020
Forecast Period CAGR %:	2.85%
Market Size Expected in 2028:	USD 29.35 Billion
Tables, Charts & Figures:	175
Pages	200
Antihypertensive Drugs Companies	Actelion, Astra Zeneca, Bayer, Boehringer Ingelheim GmbH, Boryung Pharmaceutical, Cipla, Daiichi Sankyo, Gilead, GlaxoSmithKline plc, Johnson & Johnson, JW Pharmaceutical, Kolmar Korea, Lupin, Medtronic, Merck, Novartis, Pfizer, Sanofi, Takeda, United Therapeutics, Others.
Segments Covered	By Type, By Application
Regional Analysis	North America, U.S., Mexico, Canada, Europe, UK, France, Germany, Italy, Asia Pacific, China, Japan, India, Southeast Asia, South America, Brazil, Argentina, Columbia, The Middle East and Africa, GCC, Africa, Rest of the Middle East and Africa